Galectin Therapeutics Inc

Galectin Therapeutics Inc (GALT) SEC filings

Galectin Therapeutics Inc (GALT) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Net income was -$8.2M. GALT currently screens at market cap $142.4M. The GALT filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Galectin Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

4

8-K

0

Form 4

Recent filings

8-K2.029.01

8-K exhibit

EDGAR
8-K3.029.01

8-K exhibit

EDGAR
8-K7.019.01

8-K exhibit

EDGAR
8-K5.02

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all GALT filings.

Frequently asked questions

What did GALT just say?

GALT cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are GALT SEC filings?

4 cached filings are on this page. EDGAR remains the official archive (CIK 0001133416).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.